Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sea Lane Biotechnologies developed innovative biotherapeutic technologies including Surrobodies™—a novel class of engineered proteins enabling creation of bispecific therapeutic agents and drug conjugates—and ConCIRT human antibody libraries. The company had multiple preclinical programs targeting cancer and viral infections before its acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sea Lane Biotechnologies.